SemBioSys receives milestone payments from... (echnology markets. About AVAC (http:...)

SemBioSys receives milestone payments from AVAC Ltd.

Date:4/7/2008

echnology markets.

AVAC Ltd. is a private not-for-profit company that invests in early-stage (pre-commercial) value added companies, commercially-relevant agricultural research, and as a strategic fund-of-fund investor in early stage venture capital. AVAC's primary objective is to expand Alberta's industry, with particular focus on: agri-business, renewable resources, ICT, life sciences and other industrial technology sectors. Created in 1997, AVAC has invested in over 95 early-stage companies, 47 agriculture research programs and projects, and 2 venture capital funds to date.

About Botaneco Specialty Ingredients Inc. (http://www.botaneco.ca)

From development through delivery, Botaneco manufactures and markets a branded line of ingredients that harness the naturally occurring benefits of protein protected seed oils. Botaneco provides performance, innovation and choice in creating natural, renewable and versatile delivery systems and ingredients used in the development of cosmetics, personal care and prescription topical/dermatology products beneficial to humans and the environment. Botaneco is a wholly-owned subsidiary of SemBioSys Genetics Inc.

About Hydresia(TM) (http://www.hydresia.com)

Hydresia(TM) is a base emulsion naturally derived from safflower seed oilbodies, or oleosomes, which can replace traditional emulsifiers such as petrolatum and animal and chemical byproducts in health and beauty products. Oleosomes serve as natural storehouses for the emollient oils, antioxidants and natural moisture barriers that help keep skin soft, supple and young looking. SemBioSys has developed a gentle and natural proprietary process to isolate oleosomes from the seed fully intact to provide lasting protection to the skin.

This press relea
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

Post Your Comments:

SemBioSys receives milestone payments from...(echnology markets. About AVAC (http:...)